Europe Drug Delivery Devices Market By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Others), By Device (Syringes, Inhalers, Patch Pumps, And Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Country, Competition, Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationEurope Drug Delivery Devices Market By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Others), By Device (Syringes, Inhalers, Patch Pumps, And Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Country, Competition, Forecast & Opportunities, 2028
For instance, according to the Global Cancer Observatory, in 2020, over 530,000 patients were diagnosed with breast cancer each year and accounted for approximately 29% of all cancers in women in Europe.
Rising Burden of Chronic Diseases
According to the European Society of Cardiology’s 2019 report, there are over 6 million new cases of CVD in the European Union (EU) and over 11 million in Europe in total, every year.
Growing Adoption of Advanced Technology
. For instance, in 2021, Xeris Pharmaceuticals, Inc. obtained an approval from the European Commission (EC) for Ogluo (glucagon) pre-filled pen which is used for the treatment of severe hypoglycemia in adults, adolescents, and children with age of 2 years and over with diabetes mellitus.
Download Free Sample Report
Market Segmentation
Europe drug delivery devices market is segmented into route of administration, device, end user, company, and country. Based on route of administration, the market is divided into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, and others. Based on device, the market is categorized into syringes, inhalers, patch pumps, and others. Based on end user, the market is bifurcated into hospitals & clinics, ambulatory surgery centres, and others.
Market Players
F. Hoffmann-La Roche Ltd, Antares Pharma, Novartis AG, 3M Company, Sulzer Ltd, Gerresheimer AG, Sanofi S.A., Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in Units and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Route of Administration · Device · End User · Country |
| Country scope | Germany, France, United Kingdom, Italy, Spain, Switzerland, Netherlands, Turkey, Sweden, Belgium |
| Key companies profiled | F. Hoffmann-La Roche Ltd, Antares Pharma, Novartis AG, 3M Company, Sulzer Ltd, Gerresheimer AG, Sanofi S.A., Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc, |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy